Advertisement
Review Article| Volume 20, ISSUE 2, P159-178, April 2004

Anemia in the critically ill

  • Aryeh Shander
    Correspondence
    Department of Anesthesiology, Critical Care Medicine, Pain Management and Hyperbaric Medicine, Englewood Hospital and Medical Center, Englewood, NJ 07631
    Affiliations
    Department of Anesthesiology, Critical Care Medicine, Pain Management and Hyperbaric Medicine, Englewood Hospital and Medical Center, Englewood, NJ 07631, USA

    Mount Sinai School of Medicine, Mount Sinai Hospital, New York, NY, USA
    Search for articles by this author
      The US National Center for Health Statistics, a division of the US Department of Health and Human Services, estimated in 1996 that 3.4 million Americans were living with anemia. Anemia is present in a substantial number of patients with a variety of chronic and serious diseases, including chronic kidney disease, cancer, diabetes, cardiovascular disease, HIV/AIDS, rheumatoid arthritis, and inflammatory bowel disease. Anemia is the primary cause of red blood cell transfusions. Anemia can be both acute (eg, hemorrhage) and chronic (eg, anemia of chronic disease), and it is especially prevalent and even expected in critical care settings. This article describes the underlying physiology of anemia and the various ways by which red blood cell production can be affected by ongoing disease processes [
      • Krafte-Jacobs B.
      Anemia of critical illness and erythropoietin deficiency.
      ,
      • Lee G.R.
      The anemia of chronic disease.
      ,
      • Means Jr, R.T.
      Advances in the anemia of chronic disease.
      ].
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Critical Care Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Krafte-Jacobs B.
        Anemia of critical illness and erythropoietin deficiency.
        Intensive Care Med. 1997; 23: 137-138
        • Lee G.R.
        The anemia of chronic disease.
        Semin Hematol. 1983; 20: 61-80
        • Means Jr, R.T.
        Advances in the anemia of chronic disease.
        Int J Hematol. 1999; 70: 7-12
        • Groeger J.S.
        • Guntupalli K.K.
        • Strosberg M.
        • Halpern N.
        • Raphaely R.C.
        • Cerra F.
        • et al.
        Descriptive analysis of critical care units in the United States: patient characteristics and intensive care unit utilization.
        Crit Care Med. 1993; 21: 279-291
        • Vincent J.L.
        • Baron J.F.
        • Reinhart K.
        • Gattinoni L.
        • Thijs L.
        • Webb A.
        • et al.
        Anemia and blood transfusion in critically ill patients.
        JAMA. 2002; 288: 1499-1507
        • Tchekmedyian N.S.
        Anemia in cancer patients: significance, epidemiology, and current therapy.
        Oncology (Huntingt). 2002; 16: 17-24
        • Harris J.K.
        • Harris J.W.
        The red cell: production, metabolism, destruction: normal and abnormal. 2nd edition. Harvard University Press, Boston1970
        • Guyton A.C.
        Textbook of medical physiology. 7th edition. WB Saunders, Philadelphia1986
        • Salsbury D.C.
        Anemia of prematurity.
        Neonatal Netw. 2001; 20: 13-20
        • Cazzola M.
        How and when to use erythropoietin.
        Curr Opin Hematol. 1998; 5: 103-108
        • Krafte-Jacobs B.
        • Levetown M.L.
        • Bray G.L.
        • Ruttimann U.E.
        • Pollack M.M.
        Erythropoietin response to critical illness.
        Crit Care Med. 1994; 22: 821-826
        • Rogiers P.
        • Zhang H.
        • Leeman M.
        • Nagler J.
        • Neels H.
        • Melot C.
        • et al.
        Erythropoietin response is blunted in critically ill patients.
        Intensive Care Med. 1997; 23: 159-162
        • Shorr A.F.
        • Thomas S.J.
        • Alkins S.A.
        • Fitzpatrick T.M.
        • Ling G.S.
        D-dimer correlates with proinflammatory cytokine levels and outcomes in critically ill patients.
        Chest. 2002; 121: 1262-1268
        • Pettila V.
        • Hynninen M.
        • Takkunen O.
        • Kuusela P.
        • Valtonen M.
        Predictive value of procalcitonin and interleukin 6 in critically ill patients with suspected sepsis.
        Intensive Care Med. 2002; 28: 1220-1225
        • Rodriguez R.M.
        • Corwin H.L.
        • Gettinger A.
        • Corwin M.J.
        • Gubler D.
        • Pearl R.G.
        Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness.
        J Crit Care. 2001; 16: 36-41
        • Faquin W.C.
        • Schneider T.J.
        • Goldberg M.A.
        Effect of inflammatory cytokines on hypoxia-induced erythropoietin production.
        Blood. 1992; 79: 1987-1994
        • von Ahsen N.
        • Muller C.
        • Serke S.
        • Frei U.
        • Eckardt K.U.
        Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients.
        Crit Care Med. 1999; 27: 2630-2639
        • Corwin H.L.
        • Gettinger A.
        • Rodriguez R.M.
        • Pearl R.G.
        • Gubler K.D.
        • Enny C.
        • et al.
        Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial.
        Crit Care Med. 1999; 27: 2346-2350
        • Jongen-Lavrencic M.
        • Peeters H.R.
        • Rozemuller H.
        • Rombouts W.J.
        • Martens A.C.
        • Vreugdenhil G.
        • et al.
        IL-6-induced anaemia in rats: possible pathogenetic implications for anemia observed in chronic inflammations.
        Clin Exp Immunol. 1996; 103: 328-334
        • Weiss G.
        • Wachter H.
        • Fuchs D.
        Linkage of cell-mediated immunity to iron metabolism.
        Immunol Today. 1995; 16: 495-500
        • van Iperen C.E.
        • Kraaijenhagen R.J.
        • Biesma D.H.
        • Beguin Y.
        • Marx J.J.
        • van de Wiel A.
        Iron metabolism and erythropoiesis after surgery.
        Br J Surg. 1998; 85: 41-45
        • Fuchs D.
        • Hausen A.
        • Reibnegger G.
        • Werner E.R.
        • Werner-Felmayer G.
        • Dierich M.P.
        • et al.
        Immune activation and the anaemia associated with chronic inflammatory disorders.
        Eur J Haematol. 1991; 46: 65-70
        • Haile D.J.
        Regulation of genes of iron metabolism by the iron-response proteins.
        Am J Med Sci. 1999; 318: 230-240
        • Esparza I.
        • Brock J.H.
        Release of iron by resident and stimulated mouse peritoneal macrophages following ingestion and degradation of transferrin–antitransferrin immune complexes.
        Br J Haematol. 1981; 49: 603-614
        • Kleber E.E.
        • Lynch S.R.
        • Skikne B.
        • Torrance J.D.
        • Bothwell T.H.
        • Charlton R.W.
        Erythrocyte catabolism in the inflammatory peritoneal monocyte.
        Br J Haematol. 1978; 39: 41-54
        • Weiss G.
        Iron and anemia of chronic disease.
        Kidney Int Suppl. 1999; 69: S12-S17
        • Wingard R.L.
        • Parker R.A.
        • Ismail N.
        • Hakim R.M.
        Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin.
        Am J Kidney Dis. 1995; 25: 433-439
        • Fishbane S.
        • Kowalski E.A.
        The comparative safety of intravenous iron dextran, iron saccharate, and sodium ferric gluconate.
        Semin Dial. 2000; 13: 381-384
        • Bellamy M.C.
        • Gedney J.A.
        Unrecognised iron deficiency in critical illness.
        Lancet. 1998; 352: 1903
        • Erslev A.J.
        Erythropoietin and anemia of cancer.
        Eur J Haematol. 2000; 64: 353-358
        • Gyftaki E.
        • Kesse-Elia M.
        • Mavrikakis M.
        • Papadoyanakis N.
        Iron metabolism and red cell survival in uremic patients.
        Acta Haematol. 1972; 47: 200-209
        • Higgins M.R.
        • Grace M.
        • Ulan R.A.
        • Silverberg D.S.
        • Bettcher K.B.
        • Dossetor J.B.
        Anemia in hemodialysis patients.
        Arch Intern Med. 1977; 137: 172-176
        • Biesma D.H.
        • Van de Wiel A.
        • Beguin Y.
        • Kraaijenhagen R.J.
        • Marx J.J.
        Postoperative erythropoiesis is limited by the inflammatory effect of surgery on iron metabolism.
        Eur J Clin Invest. 1995; 25: 383-389
        • Heyland D.K.
        • Cook D.J.
        • King D.
        • Kernerman P.
        • Brun-Buisson C.
        Maximizing oxygen delivery in critically ill patients: a methodologic appraisal of the evidence.
        Crit Care Med. 1996; 24: 517-524
        • Marik P.E.
        • Sibbald W.J.
        Effect of stored-blood transfusion on oxygen delivery in patients with sepsis.
        JAMA. 1993; 269: 3024-3029
        • Hebert P.C.
        • Wells G.
        • Blajchman M.A.
        • Marshall J.
        • Martin C.
        • Pagliarello G.
        • et al.
        A multi-center, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion requirements in Critical Care Investigators, Canadian Critical Care Trials Group.
        N Engl J Med. 1999; 340: 409-417
        • Vamvakas E.
        • Kaplan H.S.
        Early transfusion and length of survival in acquired immune deficiency syndrome: experience with a population receiving medical care at a public hospital.
        Transfusion. 1993; 33: 111-118
        • Vamvakas E.C.
        • Carven J.H.
        Transfusion and postoperative pneumonia in coronary artery bypass graft surgery: effect of the length of storage of transfused red cells.
        Transfusion. 1999; 39: 701-710
        • Claridge J.A.
        • Sawyer R.G.
        • Schulman A.M.
        • McLemore E.C.
        • Young J.S.
        Blood transfusions correlate with infections in trauma patients in a dose-dependent manner.
        Am Surg. 2002; 68: 566-572
        • Farion K.J.
        • McLellan B.A.
        • Boulanger B.R.
        • Szalai J.P.
        Changes in red cell transfusion practice among adult trauma victims.
        J Trauma. 1998; 44: 583-587
        • Friederich P.W.
        • Henny C.P.
        • Messelink E.J.
        • Geerdink M.G.
        • Keller T.
        • Kurth K.H.
        • et al.
        Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial.
        Lancet. 2003; 361: 201-205
        • Paganini E.P.
        Overview of anemia associated with chronic renal disease: primary and secondary mechanisms.
        Semin Nephrol. 1989; 9: 3-8
        • Paganini E.P.
        • Garcia J.
        • Abdulhadi M.
        • Lathim D.
        • Giesman J.
        • Weick J.K.
        The anemia of chronic renal failure. Overview and early erythropoietin experience.
        Cleve Clin J Med. 1989; 56: 79-86
        • Naets J.P.
        Hematologic disorders in renal failure.
        Nephron. 1975; 14: 181-194
        • Neimark M.I.
        Changes in the oxygen transport function in patients with chronic kidney failure during hemodialysis.
        Anesteziol Reanimatol. 1989; Jan–Feb: 14-17
        • Gordon M.S.
        Managing anemia in the cancer patient: old problems, future solutions.
        Oncologist. 2002; 7: 331-341
        • Lee W.R.
        • Berkey B.
        • Marcial V.
        • Fu K.K.
        • Cooper J.S.
        • Vikram B.
        • et al.
        Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85–27.
        Int J Radiat Oncol Biol Phys. 1998; 42: 1069-1075
        • Saba H.
        Anemia and cancer patients: introduction and overview.
        Cancer Control. 1998; 5: 225-456
        • Mercadante S.
        • Gebbia V.
        • Marrazzo A.
        • Filosto S.
        Anaemia in cancer: pathophysiology and treatment.
        Cancer Treat Rev. 2000; 26: 303-311
        • Kumar P.
        Impact of anemia in patients with head and neck cancer.
        Oncologist. 2000; 5: 13-18
        • Fyles A.W.
        • Milosevic M.
        • Pintilie M.
        • Syed A.
        • Hill R.P.
        Anemia, hypoxia and transfusion in patients with cervix cancer: a review.
        Radiother Oncol. 2000; 57: 13-19
        • Harrison L.B.
        • Shasha D.
        • White C.
        • Ramdeen B.
        Radiotherapy-associated anemia: the scope of the problem.
        Oncologist. 2000; 5: 1-7
        • Lane P.
        • Gross S.
        Hemoglobin as a chariot for NO bioactivity.
        Nat Med. 2002; 8: 657-658
        • McMahon T.J.
        • Moon R.E.
        • Luschinger B.P.
        • Carraway M.S.
        • Stone A.E.
        • Stolp B.W.
        • et al.
        Nitric oxide in the human respiratory cycle.
        Nat Med. 2002; 8: 711-717
        • Zhu H.
        • Jackson T.
        • Bunn H.F.
        Detecting and responding to hypoxia.
        Nephrol Dial Transplant. 2002; 17: 3-7
        • Semenza G.L.
        Perspectives on oxygen sensing.
        Cell. 1999; 98: 281-284
        • Kaelin Jr, W.G.
        How oxygen makes its presence felt.
        Genes Dev. 2002; 16: 1441-1445
        • Murray J.F.
        • Escobar E.
        • Rapaport E.
        Effects of blood viscosity on hemodynamic responses in acute normovolemic anemia.
        Am J Physiol. 1969; 216: 638-642
        • Woodson R.D.
        • Auerbach S.
        Effect of increased oxygen affinity and anemia on cardiac output and its distribution.
        J Appl Physiol. 1982; 53: 1299-1306
        • Messmer K.
        Blood rheology factors and capillary blood flow. Springer–Verlag, Berlin1991
        • Wilkerson D.K.
        • Rosen A.L.
        • Sehgal L.R.
        • Gould S.A.
        • Sehgal H.L.
        • Moss G.S.
        Limits of cardiac compensation in anemic baboons.
        Surgery. 1988; 103: 665-670
        • Hagl S.
        • Heimisch W.
        • Meisner H.
        • Erben R.
        • Baum M.
        • Mendler N.
        The effect of hemodilution on regional myocardial function in the presence of coronary stenosis.
        Basic Res Cardiol. 1977; 72: 344-364
        • Geha A.S.
        • Baue A.E.
        Graded coronary stenosis and coronary flow during acute normovolemic anemia.
        World J Surg. 1978; 2: 645-651
        • Opelz G.
        • Sengar D.P.
        • Mickey M.R.
        • Terasaki P.I.
        Effect of blood transfusions on subsequent kidney transplants.
        Transplant Proc. 1973; 5: 253-259
        • Heiss M.M.
        • Mempel W.
        • Delanoff C.
        • Jauch K.W.
        • Gabka C.
        • Mempel M.
        • et al.
        Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery.
        J Clin Oncol. 1994; 12: 1859-1867
        • Tegtmeier G.E.
        Post-transfusion cytomegalovirus infections.
        Arch Pathol Lab Med. 1989; 113: 236-245
        • Bordin J.O.
        • Bardossy L.
        • Blajchman M.A.
        Experimental animal model of refractoriness to donor platelets: the effect of plasma removal and the extent of white cell reduction on allogeneic alloimmunization.
        Transfusion. 1993; 33: 798-801
        • Bordin J.O.
        • Heddle N.M.
        • Blajchman M.A.
        Biologic effects of leukocytes present in transfused cellular blood products.
        Blood. 1994; 84: 1703-1721
        • Bordin J.O.
        • Blajchman M.A.
        Immunosuppressive effects of allogeneic blood transfusions: implications for the patient with a malignancy.
        Hematol Oncol Clin North Am. 1995; 9: 205-218
        • Murphy M.F.
        New variant Creutzfeldt–Jakob disease (nvCJD): the risk of transmission by blood transfusion and the potential benefit of leukocyte-reduction of blood components.
        Transfus Med Rev. 1999; 13: 75-83
        • Thurer R.L.
        • Luban N.L.
        • AuBuchon J.P.
        • Silver H.
        • McCarthy L.J.
        • Dzik S.
        • et al.
        Universal WBC reduction.
        Transfusion. 2000; 40: 751-752
        • Houbiers J.G.
        • Brand A.
        • van de Watering L.M.
        • Hermans J.
        • Verwey P.J.
        • Bijnen A.B.
        • et al.
        Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer.
        Lancet. 1994; 344: 573-578
        • van de Watering L.M.
        • Hermans J.
        • Houbiers J.G.
        • van den Broek P.J.
        • Bouter H.
        • Boer F.
        • et al.
        Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial.
        Circulation. 1998; 97: 562-568
        • Berezina T.L.
        • Zaets S.B.
        • Morgan C.
        • Spillert C.R.
        • Kamiyama M.
        • Spolarics Z.
        • et al.
        Influence of storage on red blood cell rheological properties.
        J Surg Res. 2002; 102: 6-12
        • Purdy F.R.
        • Tweeddale M.G.
        • Merrick P.M.
        Association of mortality with age of blood transfused in septic ICU patients.
        Can J Anaesth. 1997; 44: 1256-1261
        • Martin C.
        Age of transfused red blood cells is associated with increased ICU length of stay.
        Clin Invest Med. 1994; 17: 124
        • Lorente J.A.
        • Landin L.
        • De Pablo R.
        • Renes E.
        • Rodriguez-Diaz R.
        • Liste D.
        Effects of blood transfusion on oxygen transport variables in severe sepsis.
        Crit Care Med. 1993; 21: 1312-1318
        • Machiedo G.W.
        • Powell R.J.
        • Rush Jr, B.F.
        • Swislocki N.I.
        • Dikdan G.
        The incidence of decreased red blood cell deformability in sepsis and the association with oxygen free radical damage and multiple-system organ failure.
        Arch Surg. 1989; 124: 1386-1389
        • Hoeft A.
        • Wietasch J.K.
        • Sonntag H.
        • Kettler D.
        Theoretical limits of permissive anemia.
        Zentralbl Chir. 1995; 120: 604-613
        • Corwin H.L.
        • Krantz S.B.
        Anemia of the critically ill: acute anemia of chronic disease.
        Crit Care Med. 2000; 28: 3098-3099
        • Corwin H.L.
        • Gettinger A.
        • Pearl R.G.
        • Fink M.P.
        • Levy M.M.
        • Shapiro M.J.
        • et al.
        Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial.
        JAMA. 2002; 288: 2827-2835
        • Gabriel A.
        • Kozek S.
        • Chiari A.
        • Fitzgerald R.
        • Grabner C.
        • Geissler K.
        • et al.
        High-dose recombinant human erythropoietin stimulates reticulocyte production in patients with multiple organ dysfunction syndrome.
        J Trauma. 1998; 44: 361-367
        • van Iperen C.E.
        • Gaillard C.A.
        • Kraaijenhagen R.J.
        • Braam B.G.
        • Marx J.J.
        • van de Wiel A.
        Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients.
        Crit Care Med. 2000; 28: 2773-2778
        • Monk T.G.
        • Goodnough L.T.
        • Brecher M.E.
        • Colberg J.W.
        • Andriole G.L.
        • Catalona W.J.
        A prospective randomized comparison of three blood conservation strategies for radical prostatectomy.
        Anesthesiology. 1999; 91: 24-33
        • Goodnough L.T.
        • Shander A.
        • Brecher M.E.
        Transfusion medicine: looking to the future.
        Lancet. 2003; 361: 161-169
        • Moskowitz D.M.
        • Perelman S.I.
        • Cousinesau K.M.
        • Klein J.J.
        • Shander A.
        • Margolis E.J.
        • et al.
        Multidisciplinary management of a Jehovah's Witness patient for the removal of a renal cell carcinoma extending into the right atrium.
        Can J Anaesth. 2002; 49: 402-408